Health

sweelin® Approved in Singapore as a Food Additive expanding Amai Proteins' Regulatory Footprint into Asia

Amai Proteins has achieved a major regulatory milestone with the Singapore Food Agency (SFA) approval of sweelin®, its flagship sweet protein, for use as a sweetening agent in food and beverage products. sweelin® is a next-generation sweet protein that enables significant sugar reduction and rep...

2026-05-25 16:00 4711

Singaporeans equate net-worth with self-worth: AIA study reveals harmful financial stereotypes hold back wellbeing

SINGAPORE, May 25, 2026 /PRNewswire/ -- Stereotypes about financial success are shaping identity and perceptions of masculinity in Singapore, according to the AIA Rethink Healthy Asia Report. While Singaporeans report lower personal agreement with many traditional stereotypes compared to the rest...

2026-05-25 13:38 3913

THE FUTURE OF MEN'S HEALTH IS MEASURABLE: EMAGENE.LIFE AND ADAM HEALTH PARTNER TO ADVANCE PRECISION LONGEVITY AND FUNCTIONAL MEDICINE

Emagene.life integrates advanced biodata intelligence, functional medicine, and Avio Health AI technology through a strategic collaboration with Adam Health to support measurable male vitality and longevity. KUALA LUMPUR, Malaysia, May 25, 2026 /PRNewswire/ -- Men's health is entering a new era ...

2026-05-25 13:36 3721

/C O R R E C T I O N -- Medtronic plc/

In the news release, "Medtronic Singapore partners with Society of Colorectal Surgeons to strengthen surgical training", issued on May 25 2026 by Medtronic over PR Newswire, we are advised by the company that the caption text accompanying the image, should read "From left to right: Sharon Lew (Se...

2026-05-25 12:43 4436

ASIA PACIFIC'S LEADING DENTAL BODY CALLS FOR A PREVENTION-FIRST SHIFT IN ORAL HEALTH, BACKED BY NEW GLOBAL EVIDENCE

The Asia Pacific Dental Federation releases its first dentist-authored guidance on daily self-care — making the case that preventing oral disease is not just possible, but within reach for everyone. LISTERINE® joins APDF in championing better daily routines, backed by evidence. SINGAPORE, May 25...

2026-05-25 11:00 3094

Most Singaporeans know about LPAs, but only 1 in 3 have made one

New research by SMU highlights a gap in preparedness, socioeconomic disparities and need for stronger public support as Singapore ages SINGAPORE, May 25, 2026 /PRNewswire/ -- A new study by the Singapore Management University (SMU) Centre for Research on Successful Age...

2026-05-25 09:15 2647

From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma

SHANGHAI, May 25, 2026 /PRNewswire/ -- A 36-year-old Pakistani patient has achieved encouraging early recovery after receiving personalized CAR-T immunotherapy at Jiahui International Cancer Center in Shanghai, following exhausting standard treatments for aggressive recurrent blood cancer. Muham...

2026-05-25 08:41 2153

Informa Markets Puts Bangkok at the Center of Southeast Asia's Pharma Industry, Uniting 400 Exhibitors, Experts from 70 Countries at CPHI South East Asia

The Region's Premier Pharma Exhibition Returns to Bangkok, Elevating Thailand's Role in the ASEAN Pharmaceutical Supply Chain BANGKOK, May 24, 2026 /PRNewswire/ -- Informa Markets sets to organise CPHI South East Asia from 8–10 July 2026 at Queen Sirikit National Convention Center under the them...

2026-05-24 13:00 4657

Meet Clicklinks: The Innovation Hub for Original Drug Discovery

SHANGHAI, May 23, 2026 /PRNewswire/ -- For many participants in the innovative drug discovery arena, AI-STAL and SAI-DA are already familiar names within the Sanyou Bio ecosystem. AI-STAL is recognized as the "Grand Master Librarian" safeguarding a Super Trillion Antibody Library, while SAI-DA is...

2026-05-23 22:00 4137

79th World Health Assembly adopts resolution on hemophilia and other bleeding disorders

MONTREAL, May 23, 2026 /PRNewswire/ -- On May 22, 2026, the 79th World Health Assembly unanimously adopted a resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders. This is a historic development for our community and will help increase diagno...

2026-05-23 02:00 3836

Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias

EPLive 2026 is a two-day conference that draws the world's top cardiac electrophysiology experts AUSTIN, Texas, May 22, 2026 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its eighth international symposium on complex arrhythmias on May 28-2...

2026-05-22 21:08 5394

WHO Goodwill Ambassador Issues Rallying Cry to Accelerate International Efforts to Eliminate Leprosy: "The Last Mile Starts Now"

TOKYO, May 22, 2026 /PRNewswire/ -- Yohei Sasakawa has issued a rallying cry for the international community to step up efforts for a world without leprosy. "The last mile starts now," he said, addressing a reception held in Geneva on May 18 during the 79th World Health Assembly to mark his 25 ye...

2026-05-22 16:00 3809

Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan

Satellite symposium and exhibition engagement highlighted strong physician interest in MRD, MCED, and evidence-driven adoption of genomic testing. TAIPEI, May 22, 2026 /PRNewswire/ -- Gene Solutions , an innovative global biotechnology company advan...

2026-05-22 14:45 4683

SingHealth Receives International Awards for Healthy Ageing and Population Health Initiatives

* In recognition of its contributions to healthy ageing, SingHealth has been conferred the His Highness Sheikh Sabah Al-Ahmad Al-Jaber Al-Sabah Prize for the Promotion of Healthy Ageing by the World Health Organization. * This reflects SingHealth's growing international standing in population ...

2026-05-22 13:45 3854

Mabwell Announces Latest Clinical Data on 9MW2821 to Be Presented at 2026 ASCO Annual Meeting as Oral and Poster Presentations

SHANGHAI, May 21, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present multiple clinical study results of its novel Nectin-4-targeting ADC 9MW2821 (Bulumtatug Fuvedotin, BFv) at the 2026 American S...

2026-05-22 11:30 5277

Nuance Pharma Announces IND Clearance for Actair® Pivotal Clinical Trial in China

NMPA Approval Marks Key Milestone in Advancing House Dust Mite Allergy Immunotherapy to Chinese Patients SHANGHAI, May 22, 2026 /PRNewswire/ -- Nuance Pharma today announced that the National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application, enabl...

2026-05-22 09:50 4046

Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026

* Sacituzumab tirumotecan (sac-TMT)(佳泰莱®) plus pembrolizumab versus pembrolizumab as first-line treatment for PD-L1 positive advanced NSCLC: Results from the randomized, controlled, registrational Phase III OptiTROP-Lung05 study (Abstract #8506) * Efficacy and safety of lunbotinib fumarate (A...

2026-05-22 08:00 5404

Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting

TAIPEI, May 21, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. announces that its abstract highlighting the differentiated binding profile and preclinical efficacy ofTSY-310, a novel bispecific antibody-drug conjugate (ADC), has been selected for presentation at the American Society of Clinic...

2026-05-22 05:34 4182

Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026

At ASCO 2026, Lunit will present precision patient stratification and biomarker-driven oncology research through AI-powered HER2/IHC biomarker quantification and spatial tumor microenvironment analysis. SEOUL, South Korea, May 21, 2026 /PRNewswire/ -- Lunit, a leading provider of AI for cancer d...

2026-05-22 05:00 4666

Kelun-Biotech Announces Phase III Trial of Sacituzumab Tirumotecan (sac-TMT) versus Chemotherapy as First‑line Treatment for Advanced TNBC Met Primary Endpoint of PFS

CHENGDU, China, May 21, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study (OptiTROP-Breast03) of the Company's tropho...

2026-05-21 22:08 6273
1 ... 78910111213 ... 873